GlassScriptPhysician profile
David Rimmer
NPI 1619976636
$2,208.33
in general payments reported to CMS, 2019-2025
25 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $126 · 2021: $507 · 2022: $170 · 2023: $274 · 2024: $375 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $537.16 | 2019-2025 | Vistaseal, Echelon; Endopath, Harmonic |
| Takeda Pharmaceuticals U.S.A., INC. | $408.72 | 2020-2025 | Gattex |
| Intuitive Surgical, INC. | $398.60 | 2019-2022 | |
| Davol INC. | $117.55 | 2020-2021 | |
| Tela Bio, INC. | $77.48 | 2024 | Ovitex 2s |
| Conmed Corporation | $71.43 | 2024 | Airseal |
| Vertex Pharmaceuticals Incorporated | $63.27 | 2024-2025 | |
| Asensus Surgical, INC. | $61.28 | 2021-2023 | Senhance |
| Baxter Healthcare | $56.99 | 2019-2021 | |
| Medtronic, INC. | $56.01 | 2021-2024 | Absorbatack |
| Covidien LP | $51.54 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $47.43 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $43.64 | 2019 | |
| Cardinal Health 414 LLC | $29.03 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Pacira Pharmaceuticals Incorporated | $26.64 | 2023 | Exparel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24.74 | 2024 | |
| Focal Therapeutics, INC. | $18.60 | 2019 | |
| Smith+Nephew, INC. | $17.13 | 2023 | Pico 7, Renasys Touch, Renasys Go V2 Home |
| Zimmer Biomet Holdings, INC. | $15.91 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.31 | 2021 | |
| Shire North American Group INC | $15.11 | 2019 | |
| Merit Medical Systems INC | $14.49 | 2021 | |
| Innocoll Pharmaceuticals Limited | $14.22 | 2021 | |
| Stryker Corporation | $13.84 | 2025 | Molli |
| Baudax Bio INC. | $12.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.